iiinova — where your digital self keeps evolving

Dr. Deepak L. Bhatt

@dlbhattmd.bsky.social

77 followers 33 following 19 posts

Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, is the Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine (with Tenure) at the Icahn School of Medicine at Mount Sinai in New York City.

Posts Replies Media

Reposted by Dr. Deepak L. Bhatt

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 22/04/2026

PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischemic events: an observational study academic.oup.com/eurheartj/ar... #cardiology #cardiovascular #prevention #cardiosky #medsky

academic.oup.com

PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study

AbstractBackground and Aims. Low-density lipoprotein cholesterol (LDL-C)-lowering therapies are proven effective in atherosclerotic cardiovascular disease

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 30/04/2026

#cardiosky #cardiology #cardiovascular

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 23/04/2026

Extremely sad to hear of the passing of Icahn School of Medicine at Mount Sinai #cardiology alumnus Dr. Eugene Braunwald. His impact on medicine is immeasurable. He was a friend, mentor, and so much more. #cardiovascular #cardiosky @harvard.edu @harvardmed.bsky.social @mgbresearch.bsky.social

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 22/04/2026

PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischemic events: an observational study academic.oup.com/eurheartj/ar... #cardiology #cardiovascular #prevention #cardiosky #medsky

academic.oup.com

PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study

AbstractBackground and Aims. Low-density lipoprotein cholesterol (LDL-C)-lowering therapies are proven effective in atherosclerotic cardiovascular disease

Reposted by Dr. Deepak L. Bhatt

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 18/12/2025

#cardiology #cardiovascular #diabetes #cardiosky #medsky

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 18/12/2025

#cardiology #cardiovascular #diabetes #cardiosky #medsky

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 18/12/2025

SURPASS-CVOT now out in @nejm.org! #cardiology #cardiovascular #diabetes #cardiosky #endosky #medsky

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 13/12/2025

Out today! The 13th Edition of Braunwald's Heart Disease. #cardiology #cardiovascular

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 13/10/2025

Great night at the Mount Sinai Health System Board of Trustees Dinner with my former boss, Dr. Toby Cosgrove, prior CEO of @clevelandclinic.bsky.social, and current boss, Dr. Brendan Carr, CEO of Mount Sinai Health System!

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 18/09/2025

Mount Sinai Fuster Heart Hospital celebration of our #2 national ranking in US News & World Report. #cardiology #cardiovascular

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 01/07/2025

Welcome to our new #cardiology fellows at Mount Sinai Hospital!

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 22/05/2025

Just out in @science.org Translational Medicine - more data supporting the pleiotropic benefits of EPA: Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity www.science.org/doi/10.1126/... #cardiology #CardioSky #cardiovascular #MedSky #EndoSky

Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity

Dose-dependent platelet inhibition by icosapent ethyl contributes to beneficial effects of polyunsaturated omega-3 fatty acids.

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 14/05/2025

#cardiology #cardiovascular #MedSky #EndoSky #CardioSky #RenalSky @thelancetendo.bsky.social @thelancet.bsky.social

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 14/05/2025

#cardiology #cardiovascular #MedSky #CardioSky

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 30/04/2025

#Education #MBA #EMBA

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 27/04/2025

Potential impact of the ongoing VICTORION-1 PREVENT trial - bottom line, millions of patients could be eligible for therapy with inclisiran. #CardioSky #MedSky #Cardiology #Cardiovascular #Prevention @ajpcardio.bsky.social

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 25/04/2025

Wonderful 19th VF Society meeting last night at The New York Academy of Medicine! #cardiology #cardiovascular

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 24/04/2025

Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy | NEJM AI ai.nejm.org/doi/full/10.... #cardiology #AI

Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy

Despite optimism for the incorporation of deep-learning (DL) algorithms into clinical practice, there is a lack of prospective data on how U.S. Food and Drug Administration (FDA)–cleared algorithms...

Dr. Deepak L. Bhatt @dlbhattmd.bsky.social · 23/04/2025

Key Insights for Thromboembolic Disease Prevention, now available online at ms.spr.ly/6012W7yq8 #cardiology #cardiovascular #CME @medscape.com @medscape.org

AHA Conference Recap: Key Insights for Thromboembolic Disease Prevention

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.